Clinical trialNCT04305470CompletedPhase 3Interventional

Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma

SponsorNX Development CorpEnrollment108Meningioma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This Phase 3 open-label single-arm study is designed to investigate the safety, diagnostic performance, and clinical usefulness of Gleolan for the real time detection and visualization of meningiomas during tumor resection surgery. The study is planned to run for 15 months with individual study participation lasting for approximately 2 months.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bernard Bendok, MD
Mayo Clinic
Principal Investigator
clinicaltrials.gov ↗
Walter Stummer, MD
Universitätsklinikum Münster
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria

Medical University of Vienna
Vienna, Austria

Germany

University Hospital Münster
Münster, Germany

United States

Mayo Clinic
Phoenix, Arizona, United States
University of California San Diego
La Jolla, California, United States
Keck Hospital of Usc
Los Angeles, California, United States
Providence St. Joseph Hospital
Orange, California, United States
Swedish Medical Center
Englewood, Colorado, United States
University of Miami
Coral Gables, Florida, United States
Baptist Health South Florida
Miami, Florida, United States
Southern Illinois University
Springfield, Illinois, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Henry Ford Health System
Detroit, Michigan, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
Nyu Langone Health
Brooklyn, New York, United States
University of Pennsylvania- Penn Medicine
Philadelphia, Pennsylvania, United States
Upmc
Pittsburgh, Pennsylvania, United States
Md Anderson
Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Gleolan

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Oct 2020
Primary completion: 7 Nov 2022
Completion: 13 Dec 2022
Last update posted: 18 May 2026
Registered enrollment: 108
Registry id: NCT04305470

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.